Yearly Archives: 2026
Owlet® Announces Strategic AI Partnership with webAI to Power the Next Generation of Personalized Infant Health and Sleep Insights
Strategic investment in private AI infrastructure positions Owlet to compound value from its growing base of proprietary infant wellness data.
Nathan Tenney, Aide to Rep. Maloy Tours Utah Life Sciences Companies
Nathan Tenney, Aide to Rep. Maloy Tours Utah Life Sciences Companies
Behavioral Health Assessment Using Vocal Biomarkers
Behavioral Health Assessment Using Vocal Biomarkers
Wasatch Health Announces Expanded Investment Platform to Accelerate Life Sciences Growth in Utah and the Mountain West
Wasatch Health Announces Expanded Investment Platform to Accelerate Life Sciences Growth in Utah and the Mountain West
Owlet’s First Baby Sleep Report Analyzes Data from Over 1.2 Million Owlet Monitored Babies
Report draws on Owlet’s massive infant sleep dataset, one of the world’s largest, to reveal how babies sleep – evaluating bedtimes, wake-ups, sleep stretches, and biometric trends
PhotoPharmics Announces Publication of Phase 2 Clinical Trial Results in Neurotherapeutics and Its Role in the Company’s Phase 3/Pivotal Clinical Trial
Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of Celeste® in Parkinson’s Disease
SPARC Health Announces Second Cohort Applications, Building on Inaugural Program Success
SPARC Health, a collaborative effort between Park City Angels (PCA), BioUtah, BioHive, in partnership with Governor’s Office of Economic Opportunity (GOEO), announced applications are now open for its second cohort program.
SPARC Health, BioUtah Co-Host Shark Tank-Style Pitch Competition at 2026 Wilson Sonsini Entrepreneur & Investor Life Sciences Summit
Taking place on March 12, 2026, at the Hilton Salt Lake City Center, the competition provides early-stage healthcare companies with a premier platform to showcase innovations to experienced investors and industry leaders.
JP Morgan Healthcare Conference Recap – Photo Gallery
Check out the photo gallery from the 2026 JP Morgan Healthcare conference in San Francisco.
Haemonetics to Acquire Vivasure Medical
The purchase is expected to expand Haemonetics’ impact in fast-growing markets for structural heart and endovascular procedures.
BD Receives FDA 510(k) Clearance for EnCor EnCompass™ Breast Biopsy and Tissue Removal System
State-of-the-art, multi-modality breast biopsy system slated to be in the market in early 2026
DiscGenics Treats First Patient in Phase 3 Clinical Trial of IDCT (Rebonuputemcel) for Symptomatic Mild-to-Moderate Lumbar Degenerative Disc Disease
DiscGenics Treats First Patient in Phase 3 Clinical Trial of IDCT (Rebonuputemcel) for Symptomatic Mild-to-Moderate Lumbar Degenerative Disc Disease
